Press Resease

Lymphoma Treatment Market - Global Industry Analysis

Lymphoma Treatment Market by Type (Non-Hodgkin Lymphoma and Hodgkin Lymphoma) and Drug (Opdivo, Adcetris, Rituxan, Keytruda, Revlimid, Imbruvica, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Published Date: 25-Oct-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4942 Status : Published

Global demand for lymphoma treatment market was valued at approximately USD 12.1 Billion in 2018, and is expected to generate revenue of around USD 22.3 Billion by end of 2025, growing at a CAGR of around 9.2% between 2019 and 2025.

Description

The report covers forecast and analysis for the lymphoma treatment market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the lymphoma treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the lymphoma treatment market on a global as well as regional level.

According to the report, global demand for lymphoma treatment market was valued at approximately USD 12.1 Billion in 2018, and is expected to generate revenue of around USD 22.3 Billion by end of 2025, growing at a CAGR of around 9.2% between 2019 and 2025.

In order to give the users of this report a comprehensive view on the lymphoma treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.

Global Lymphoma Treatment Market

The report provides company market share analysis in order to give a broader overview of the key players in the lymphoma treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the lymphoma treatment market on global and regional basis.

Lymphoma is a cancer that arises in infection-combatting cells of the immune system, known as lymphocytes. Such cells are in the spleen, lymph nodes, bone marrow, thymus, and other portions of the body. In lymphoma, lymphocytes modify and develop out of control. There are two key types of lymphoma: Non-Hodgkin Lymphoma and Hodgkin Lymphoma.

Factors such as increasing lymphoma cases, launch of new drugs will act as major driving factors in the growth of global lymphoma treatment market. FDA approvals and efforts taken by governments to create awareness will act as an opportunity for the market players in the lymphoma treatment market. Nonetheless, lack of awareness, high cost of lymphoma drugs, and dearth of skilled researchers will restrict the growth of global lymphoma treatment market.

The global lymphoma treatment market has been split into type, drug, and region. Based on type, lymphoma treatment market has been segmented into non-Hodgkin lymphoma and Hodgkin lymphoma. The non-Hodgkin lymphoma segment accounted for the highest market share in 2018 due to availability of treatment options. The drug segment has been segmented into opdivo, adcetris, rituxan, keytruda, revlimid, imbruvica, and others. The revlimid segment accounted for the highest market share in 2018.

North America will be the leading region during the forecast period. High investment in research and development of lymphoma treatment and presence of major manufacturers will boost the market growth in this region. Europe is expected to be the second major market. The key reasons are presence of key market players and advantageous reimbursement scenario. Asia Pacific will grow at rapid rate over the forecast time-frame due to launch of novel products. The market in Latin America will grow at a substantial rate during the estimate period. The Africa and Middle Eastern region is expected to exhibit definite progression in the anticipated time-frame.

The report also includes detailed profiles of key players such as Celgene Corporation, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Seattle Genetics, Inc., Johnson & Johnson, Takeda Pharmaceutical Company Ltd., Abbott Laboratories, and Eli Lilly and Company among others.

This report segments the Global Lymphoma Treatment Market as follows:

Global Lymphoma Treatment Market: By Type

  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma

Global Lymphoma Treatment Market: By Drug

  • Opdivo
  • Adcetris
  • Rituxan
  • Keytruda
  • Revlimid
  • Imbruvica
  • Others

Global Lymphoma Treatment Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Lymphoma Treatment Market, 2015–2025 (USD Million)
    • 2.2. Global Lymphoma Treatment Market: Snapshot
  • Chapter 3. Global Lymphoma Treatment Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry ecosystem analysis
    • 3.3. Deployment landscape
    • 3.4. Lymphoma Treatment Market: Market Dynamics
    • 3.5. Market Drivers
      • 3.5.1. Driver 1
      • 3.5.2. Driver 2
    • 3.6. Restraints
      • 3.6.1. Restraint 1
      • 3.6.2. Restraint 2
    • 3.7. Opportunity
      • 3.7.1. Government Funding and Support
    • 3.8. Porter’s Five forces Analysis
    • 3.9. Market Attractiveness Analysis
      • 3.9.1. Market Attractiveness Analysis by Type
      • 3.9.2. Market Attractiveness Analysis by Drug
      • 3.9.3. Market Attractiveness Analysis by Region
  • Chapter 4. Global Lymphoma Treatment Market – Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Lymphoma Treatment Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launches
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
  • Chapter 5. Global Lymphoma Treatment Market –Type Analysis
    • 5.1. Global Lymphoma Treatment Market Overview: by Type
      • 5.1.1. Global Lymphoma Treatment Market Share, by Type,2018 and 2025
    • 5.2. Non Hodgkin Lymphoma
      • 5.2.1. Global Lymphoma Treatment Market for Non Hodgkin Lymphoma, 2015–2025 (USD Million)
    • 5.3. Hodgkin Lymphoma
      • 5.3.1. Global Lymphoma Treatment Market for Hodgkin Lymphoma, 2015–2025 (USD Million)
  • Chapter 6. Global Lymphoma Treatment Market –Drug Segment Analysis
    • 6.1. Global Lymphoma Treatment Market Overview: by Drug Segment
      • 6.1.1. Global Lymphoma Treatment Market Share, by Drug Segment, 2018 and 2025
    • 6.2. Opdivo
      • 6.2.1. Global Lymphoma Treatment Market by Opdivo, 2015–2025 (USD Million)
    • 6.3. Adcetris
      • 6.3.1. Global Lymphoma Treatment Market # by Adcetris, 2015–2025 (USD Million)
    • 6.4. Rituxan
      • 6.4.1. Global Lymphoma Treatment Market byRituxan, 2015–2025 (USD Million)
    • 6.5. Keytruda
      • 6.5.1. Global Lymphoma Treatment Market by Keytruda, 2015–2025 (USD Million)
    • 6.6. Revlimid
      • 6.6.1. Global Lymphoma Treatment Market by Revlimid, 2015–2025 (USD Million)
    • 6.7. Imbruvica
      • 6.7.1. Global Lymphoma Treatment Market by Imbruvica, 2015–2025 (USD Million)
    • 6.8. Others
      • 6.8.1. Global Lymphoma Treatment Market by Others, 2015–2025 (USD Million)
  • Chapter 7. Global Lymphoma Treatment Market - Regional Analysis
    • 7.1. Global Lymphoma Treatment Market Overview: by Region
      • 7.1.1. Global Lymphoma Treatment Marketshare, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Lymphoma Treatment Market , 2015–2025 (USD Million)
      • 7.2.2. North America Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
      • 7.2.3. North America Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.2.4.2. The U.S. Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.2.5.2. Rest of North America Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Lymphoma Treatment Market , 2015–2025 (USD Million)
      • 7.3.2. Europe Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
      • 7.3.3. Europe Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.3.4. UK
        • 7.3.4.1. U.K.Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.3.4.2. U.K. Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.3.5.2. France Lymphoma Treatment Market # Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.3.6.2. Germany Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.3.7.2. Rest of Europe Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Lymphoma Treatment Market, 2015–2025 (USD Million)
      • 7.4.2. Asia Pacific Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
      • 7.4.3. Asia Pacific Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.4.4.2. China Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.4.5.2. Japan Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.4.6.2. India Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Lymphoma Treatment Market # Revenue, by Type,2015–2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Lymphoma Treatment Market, 2015–2025 (USD Million)
      • 7.5.2. Latin America Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
      • 7.5.3. Latin America Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Waterrproof Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.5.4.2. Brazil Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
      • 7.5.5. Rest of Latinamerica
        • 7.5.5.1. Rest of Latinamerica Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
        • 7.5.5.2. Rest of Latinamerica Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Lymphoma Treatment Market, 2015–2025 (USD Million)
      • 7.6.2. The Middle East and Africa Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
      • 7.6.3. The Middle East and Africa Lymphoma Treatment Market Revenue, by Drug Segment, 2015–2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Celgene Corporation
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Bristul-Myers Squibb Company
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. F. Hoffmann-La Roche Ltd.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Merck & Co., Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Seattle Genetics, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Johnson & Johnson
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Takeda Pharmaceutical Company Ltd.
      • 8.7.1. Financials
      • 8.7.2. Product Portfolio
      • 8.7.3. Business Strategy
      • 8.7.4. Recent Developments
    • 8.8. Abbott Laboratories
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. Eli Lilly
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Developments
    • 8.10. Aeterna Zentaris, Inc
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Lymphoma Treatment Market, 2015–2025 (USD Million)
4. Porter’s Five forces Analysis
5. Global Lymphoma Treatment Market Attractiveness, by Type
6. Global Lymphoma Treatment Market Attractiveness, by Drug 
7. Global Lymphoma Treatment Marketmarket Share, for Type, 2018 and 2025
8. Global Lymphoma Treatment Market forNon Hodgkin Lymphoma, 2015–2025 (USD Million)
9. Global Lymphoma Treatment Market forHodgkin Lymphoma,2015–2025 (USD Million)
10. Global Lymphoma Treatment Market Share, by Drug, 2018 and 2025
11. Global Lymphoma Treatment Market by Opdivo, 2015–2025 (USD Million)
12. Global Lymphoma Treatment Market by Adcetris, 2015–2025 (USD Million) 
13. Global Lymphoma Treatment Market by Rituxan, 2015–2025 (USD Million)
14. Global Lymphoma Treatment Market by Keytruda, 2015–2025 (USD Million)
15. Global Lymphoma Treatment Market by Revlimid, 2015–2025 (USD Million)
16. Global Lymphoma Treatment Market by Imbruvica, 2015–2025 (USD Million)
17. Global Lymphoma Treatment Market by Others, 2015–2025 (USD Million)
18. Global Lymphoma Treatment Market Share, by Region, 2018and 2025
19. North America Lymphoma Treatment Market, 2015–2025 (USD Million)
20. Europe Lymphoma Treatment Market , 2015–2025 (USD Million)
21. Asia Pacific Lymphoma Treatment Market, 2015–2025 (USD Million)
22. Latin America Lymphoma Treatment Market , 2015–2025 (USD Million)
23. The Middle East and Africa Lymphoma Treatment Market , 2015–2025 (USD Million)


List of Tables

1. Global Lymphoma Treatment Market: Snapshot
2. Drivers of The Lymphoma Treatment Market: Impact Analysis
3. Restraints of The Lymphoma Treatment Market: Impact Analysis
4. North America Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
5. North America Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
6. The U.S. Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
7. The U.S. Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
8. Rest of North America Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
9. Rest of North America Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
10. Europe Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
11. Europe Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
12. U.K. Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
13. U.K.Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
14. France Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
15. France Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
16. Germany Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
17. Germany Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
18. Rest of Europe Lymphoma Treatment Market  Revenue, by Type,2015–2025 (USD Million)
19. Rest of Europe Lymphoma Treatment Market  Revenue, by Drug, 2015–2025 (USD Million)
20. Asia Pacific Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
21. Asia Pacific Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
22. China Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
23. China Lymphoma Treatment Market  Revenue, by Drug, 2015–2025 (USD Million)
24. Japan Lymphoma Treatment Market  Revenue, by Type,2015–2025 (USD Million)
25. Japan Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
26. India Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
27. India Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
28. Rest of Asia Pacific Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
29. Rest of Asia Pacific Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
30. Latin America Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
31. Latin America Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
32. Brazil Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
33. Brazil Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
34. Rest of Latin America Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
35. Rest of Latin America Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
36. The Middle East and Africa Lymphoma Treatment Market Revenue, by Type,2015–2025 (USD Million)
37. The Middle East and Africa Lymphoma Treatment Market Revenue, by Drug, 2015–2025 (USD Million)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed